The findings of this study suggest that metabolic bariatric surgery was associated with more weight loss at lower ongoing costs compared with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in ...

The findings of this study suggest that metabolic bariatric surgery was associated with more weight loss at lower ongoing costs ...

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live ...

WEIGHT loss injections like Mounjaro and Wegovy are hailed as the “miracle” in obesity treatment. But are they really any ...

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live ...

Roughly one out of every two people who start taking semaglutide (Wegovy; Novo Nordisk) to lose weight will stop taking the medication within a year, according to a large population-based study out of ...

For obese patients, bariatric surgery achieves greater weight loss at lower ongoing cost when compared to the class of medications commonly known as GLP-1s, according to a new study authored by ...

UNDER EMBARGO Tuesday, September 16, 2025, 05:00 a.m. ET, CLEVELAND: A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be ...

That means shifting cooking methods, moderating portions, and tackling obesogenic environments like 24-hour eateries and ...

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% ...